Study the effect of vitamin D3 in type 2 diabetic Iraqi patients with chronic kidney diseases
View/
Metadata
Show full item record
URI
Collections
Abstract
Low vitamin D levels are associated with mortality in hemodialysis (HD) patients; however, the serum
vitamin D thresholds are unclear. This study aimed to identify the vitamin D level below which mortality increases in
HD patients. This study was designed to evaluate the vitamin D3 levels in Iraqi patients with chronic kidney disease
and type 2 diabetes for both genders. Sixty Iraqi patients with chronic kidney disease and type 2 diabetes depended the
hemodialysis duration less than 1 year; their age ranged between (33-60) years and compared with 30 healthy subjects
as control group; their age ranged between (30-55) years, who were attending Al-Yarmok Teaching Hospital through
September 2019 to March 2020. Anthropometric and biochemical parameters were measured for patients and controls.
The baseline characteristics of study population are shown in Table 1. There were significant increases (p < 0.05) in
glycemic test, urea, total cholesterol, triacylglycerol, low density lipoprotein cholesterol. While, there were significant
decreases (p < 0.05) in high density lipoprotein cholesterol, glomerular filtration rate, and vitamin D3 in patients
group as compared to the controls. Moreover, there were elevations in age and body mass index in patients group as
compared to the controls. There were significant increases (p < 0.05) in fasting serum glucose, serum total cholesterol,
triacylglycerol, and low-density lipoprotein cholesterol. While, there were significant decreases in high density
lipoprotein cholesterol, glomerular filtration rate, and vitamin D3 in female patients as compared to the males.
Moreover, there were elevations in body mass index, urea, and creatinine in female patients as compared to the males.
Hypovitaminosis D was seen in Chronic Kidney disease (CKD( patients in this study, which encourage further work to
assess whether the reference vitamin D level currently used in the general population is applicable to HD patients.